BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38854001)

  • 1. Pink1/Parkin deficiency alters circulating lymphocyte populations and increases platelet-T cell aggregates in rats.
    Manganaro JE; Emanuel K; Lamberty BG; George JW; Stauch KL
    Res Sq; 2024 May; ():. PubMed ID: 38854001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease relevant pathological features are manifested in male Pink1/Parkin deficient rats.
    Lamberty BG; Estrella LD; Mattingly JE; Emanuel K; Trease A; Totusek S; Sheldon L; George JW; Almikhlafi MA; Farmer T; Stauch KL
    Brain Behav Immun Health; 2023 Aug; 31():100656. PubMed ID: 37484197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PINK1 and Parkin complementarily protect dopaminergic neurons in vertebrates.
    Matsui H; Gavinio R; Asano T; Uemura N; Ito H; Taniguchi Y; Kobayashi Y; Maki T; Shen J; Takeda S; Uemura K; Yamakado H; Takahashi R
    Hum Mol Genet; 2013 Jun; 22(12):2423-34. PubMed ID: 23449626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PINK1/Parkin-Dependent Mitochondrial Surveillance: From Pleiotropy to Parkinson's Disease.
    Mouton-Liger F; Jacoupy M; Corvol JC; Corti O
    Front Mol Neurosci; 2017; 10():120. PubMed ID: 28507507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.
    Clark IE; Dodson MW; Jiang C; Cao JH; Huh JR; Seol JH; Yoo SJ; Hay BA; Guo M
    Nature; 2006 Jun; 441(7097):1162-6. PubMed ID: 16672981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PARIS induced defects in mitochondrial biogenesis drive dopamine neuron loss under conditions of parkin or PINK1 deficiency.
    Pirooznia SK; Yuan C; Khan MR; Karuppagounder SS; Wang L; Xiong Y; Kang SU; Lee Y; Dawson VL; Dawson TM
    Mol Neurodegener; 2020 Mar; 15(1):17. PubMed ID: 32138754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease.
    Triplett JC; Zhang Z; Sultana R; Cai J; Klein JB; Büeler H; Butterfield DA
    J Neurochem; 2015 Jun; 133(5):750-65. PubMed ID: 25626353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of electroacupuncture on mitophagy mediated by SIRT3/PINK1/Parkin pathway in Parkinson's disease mice.
    Zhang GJ; Wang Y; Li JL; Ma J; Wang YC
    Zhen Ci Yan Jiu; 2024 Mar; 49(3):221-230. PubMed ID: 38500318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkin- and PINK1-Dependent Mitophagy in Neurons: Will the Real Pathway Please Stand Up?
    Grenier K; McLelland GL; Fon EA
    Front Neurol; 2013; 4():100. PubMed ID: 23882257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease.
    Stauch KL; Totusek S; Farmer T; Lamberty BG; Dyball KN; Almikhlafi MA; Fox HS
    J Vis Exp; 2021 Jan; (167):. PubMed ID: 33522500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PINK1/Parkin pathway regulates mitochondrial dynamics and function in mammalian hippocampal and dopaminergic neurons.
    Yu W; Sun Y; Guo S; Lu B
    Hum Mol Genet; 2011 Aug; 20(16):3227-40. PubMed ID: 21613270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-degron-mediated degradation and regulation of mitochondrial PINK1 kinase.
    Eldeeb MA; Ragheb MA
    Curr Genet; 2020 Aug; 66(4):693-701. PubMed ID: 32157382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.
    Aimé P; Sun X; Zareen N; Rao A; Berman Z; Volpicelli-Daley L; Bernd P; Crary JF; Levy OA; Greene LA
    J Neurosci; 2015 Jul; 35(30):10731-49. PubMed ID: 26224857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular interaction between parkin and PINK1 in mammalian neuronal cells.
    Um JW; Stichel-Gunkel C; Lübbert H; Lee G; Chung KC
    Mol Cell Neurosci; 2009 Apr; 40(4):421-32. PubMed ID: 19167501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.
    Hennis MR; Marvin MA; Taylor CM; Goldberg MS
    Neurobiol Dis; 2014 Feb; 62():113-23. PubMed ID: 24075852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson's disease.
    Koentjoro B; Park JS; Sue CM
    Sci Rep; 2017 Mar; 7():44373. PubMed ID: 28281653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson's disease.
    Ge P; Dawson VL; Dawson TM
    Mol Neurodegener; 2020 Mar; 15(1):20. PubMed ID: 32169097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PINK1-Parkin signaling in Parkinson's disease: Lessons from Drosophila.
    Imai Y
    Neurosci Res; 2020 Oct; 159():40-46. PubMed ID: 32035987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of parkin aggregates and enhanced PINK1 accumulation during the pathogenesis of Parkinson's disease.
    Um JW; Park HJ; Song J; Jeon I; Lee G; Lee PH; Chung KC
    Biochem Biophys Res Commun; 2010 Mar; 393(4):824-8. PubMed ID: 20171192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.